Metabolic Screening and Monitoring Guidelines for Adults

Core Laboratory Tests for Metabolic Assessment

• Fasting plasma glucose should be included in the adult metabolic work‑up to screen for diabetes and pre‑diabetes – recommended by the American Diabetes Association (ADA) guidelines. 1
• Hemoglobin A1c is preferred over fasting glucose alone for diabetes screening; an A1c ≥ 6.5 % defines diabetes and 5.7–6.4 % defines pre‑diabetes – ADA recommendation. 1
• A complete fasting lipid profile (total cholesterol, LDL‑C, HDL‑C, triglycerides, and calculated non‑HDL‑C) is required for cardiovascular risk assessment – ADA/ACC consensus. 2
• A complete blood count (CBC) should be obtained to provide baseline hematologic assessment and to screen for anemia, infection, and hematologic disorders – NCCN (National Comprehensive Cancer Network) guidance. 3

Risk‑Stratified Screening Intervals

• Adults ≥ 35 years with normal baseline results should be screened every 3 years – ADA recommendation. 1
• Screening should be initiated earlier and performed more frequently in individuals with BMI ≥ 25 kg/m² (≥ 23 kg/m² in Asian Americans) who have additional risk factors (family history, high‑risk ethnicity, hypertension, low HDL, high triglycerides, physical inactivity, CVD, PCOS, or insulin‑resistance conditions) – ADA guidance. 1
• People with pre‑diabetes (A1c 5.7–6.4 % or fasting glucose 100–125 mg/dL) require annual metabolic testing – ADA recommendation. 1
• Individuals with a history of gestational diabetes need lifelong testing at least every 3 years – ADA recommendation. 1

Metabolic Syndrome Diagnostic Criteria

• Metabolic syndrome is diagnosed when ≥ 3 of the following are present:
  Reference: Metabolism: Clinical and Experimental (2024) and Diabetes Care (2004). [2][4]

Target Values for Key Metabolic Parameters

Monitoring Frequency Based on Clinical Status

• Normal baseline results → repeat screening at least every 3 years – ADA. 1
• Prediabetes or metabolic syndrome → comprehensive reassessment annually – ADA & Metabolism guideline. [1][2]
• Established diabetes or chronic kidney disease → monitoring every 3–6 months (or as clinically indicated) – Metabolism guideline. 2

Common Pitfalls and Corrective Measures

• Corrected sodium calculation: In hyperglycemic patients, add 1.6 mEq/L to measured sodium for each 100 mg/dL increase in glucose to avoid pseudohyponatremia. – ADA/Diabetes Care (2004). 4
• Ketone assessment in DKA: Do not rely on nitroprusside testing alone; β‑hydroxybutyrate measurement is required for accurate diagnosis. – ADA/Diabetes Care (2004). 4

Primary Care Laboratory Testing for Adults

Core Laboratory Tests

• The American Diabetes Association recommends screening with HbA1c, fasting plasma glucose (FPG), or 2-hour oral glucose tolerance test (OGTT) for all adults aged 35 years and older, with a screening frequency of every 3 years if initial results are normal 6
• A fasting lipid profile (total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides) should be obtained to assess cardiovascular risk, with repeat testing every 6-12 months in patients with identified risk factors 7
• Blood pressure measurement is essential and should be performed annually using proper technique 7
• Complete blood count (CBC) provides baseline hematologic assessment 7, 8
• Comprehensive metabolic panel including electrolytes, creatinine with estimated glomerular filtration rate (eGFR), liver function tests (ALT, AST, total bilirubin, alkaline phosphatase) should be considered 7, 8
• Thyroid-stimulating hormone (TSH) should be considered as part of basic laboratory evaluation, particularly if symptoms suggest thyroid dysfunction 9, 10
• Urinalysis to screen for proteinuria, hematuria, or other renal abnormalities should be performed 7, 8

Risk-Based Screening

• Syphilis serology (RPR or VDRL), gonorrhea, and chlamydia testing should be performed if the patient has risk factors for sexually transmitted diseases, including multiple sexual partners or new partners, with annual testing for those at risk 11, 8
• Hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBsAb), hepatitis B core antibody (anti-HBc), and hepatitis C antibody should be obtained based on risk factors including injection drug use, multiple sexual partners, or occupational exposure 8
• If BMI ≥25 kg/m², the patient meets criteria for enhanced metabolic screening, including waist circumference measurement and consideration of obstructive sleep apnea screening 6, 9

Important Clinical Considerations

• Failing to use proper blood pressure measurement technique leads to over-diagnosis and over-treatment of hypertension 7
• Ordering non-fasting lipid panels when fasting values are required for accurate cardiovascular risk assessment is not recommended 7
• Using point-of-care HbA1c devices for diagnosis without quality assurance participation is not recommended, as only laboratory-based NGSP-certified methods should be used for diagnostic purposes 6
• Overlooking family history assessment significantly impacts screening recommendations for diabetes, cardiovascular disease, and cancer 9, 12